Mixed shell mesoporous silica nanoparticles for controlled drug encapsulation and delivery

Nanomedicine (Lond). 2017 Nov;12(22):2699-2711. doi: 10.2217/nnm-2017-0216. Epub 2017 Oct 2.

Abstract

Aim: Smart mesoporous silica nanoparticles (MSNs) with mixed polymeric shell (MS-MSNs) were prepared to realize controlled encapsulation and responsive delivery of anticancer drugs.

Materials & methods: Two kinds of polymers, including nonthermoresponsive poly(ethylene glycol) and thermoresponsive poly(N-isopropyl acrylamide), were grafted onto the outlets of the MSNs through acidic liable Schiff base bonds.

Results: Poly(N-isopropyl acrylamide) chains could control the release rate of drugs through phase transition, while poly(ethylene glycol) chains could maintain the colloid stability of MSNs. Drugs can be released through the gradual hydrolysis of Schiff base bonds in tumor acidic environment.

Conclusion: The MS-MSNs gave consideration to both the responsiveness and stability of carriers, and could realize the release of drugs as much as possible in tumor tissues.

Keywords: benzoic-imine; drug delivery; mesoporous silica.

MeSH terms

  • Acrylic Resins / chemistry
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / chemistry*
  • Cell Survival
  • Doxorubicin / administration & dosage
  • Doxorubicin / chemistry
  • Drug Carriers / chemical synthesis*
  • Drug Liberation
  • HCT116 Cells
  • Humans
  • Nanocapsules / chemistry*
  • Polyethylene Glycols / chemistry
  • Porosity
  • Silicon Dioxide / chemistry*

Substances

  • Acrylic Resins
  • Antineoplastic Agents
  • Drug Carriers
  • Nanocapsules
  • poly-N-isopropylacrylamide
  • Polyethylene Glycols
  • Silicon Dioxide
  • Doxorubicin